Platelet Dysfunction Detected by Thromboelastography with Platelet Mapping Contributes to Hematoma Expansion and Poor Outcome in Patients with Intracerebral Hemorrhage

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026609

Enrollment

Unknown

Registered

2019-10-16

Start date

2019-11-01

Completion date

Unknown

Last updated

2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage

Interventions

hematoma enlargement group and non-enlargement group:N/A

mRS 3 group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged more than 18 years; 2. Patient with intracerebral hemorrhage detected by non-contrast computed tomography (NCCT); 3. Initial CT scanned within 6 hours after symptoms onset, and follow-up CT available within 48 hours after the baseline CT scan; 4. Thromboelastography with platelet mapping obtained on admission.

Exclusion criteria

Exclusion criteria: 1. Traumatic intracranial hemorrhage;intracranial tumor or vascular malformations presumed to be the cause of the hemorrhage;primary intraventricular hemorrhage;hemorrhagic conversion of acute ischemic stroke; 2. Patients who were operated on before the follow-up CT scan; 3. Patients with antiplatelet or anticoagulant treatment.

Design outcomes

Primary

Measure	Time frame
AA inhibition;ADP inhibition;Volume of Hematoma;Prognostic analysis;Is it surgery or epilepsy;	—

Secondary

Measure	Time frame
Blood routine;Coagulation function;	—

Countries

China

Contacts

Public ContactQiuguang He

The Second Affiliated Hospital of Chongqing Medical University

598381027@qq.com+86 18716469367

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026